Company registration number 10891917 (England and Wales)
CLAIRE BAILEY GYNAECOLOGY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
PAGES FOR FILING WITH REGISTRAR
CLAIRE BAILEY GYNAECOLOGY LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
CLAIRE BAILEY GYNAECOLOGY LIMITED
BALANCE SHEET
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
28,320
36,595
Current assets
Debtors and prepayments
4
14,087
10,845
Cash at bank
24,289
24,150
38,376
34,995
Creditors: amounts falling due within one year
5
(16,922)
(13,584)
Net current assets
21,454
21,411
Total assets less current liabilities
49,774
58,006
Provisions for liabilities
(811)
(1,504)
Net assets
48,963
56,502
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
48,962
56,501
Total equity
48,963
56,502
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and signed by the director and authorised for issue on 18 April 2026
Mrs C E Trainor
Director
Company Registration No. 10891917
CLAIRE BAILEY GYNAECOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
- 2 -
1
Accounting policies
Company information
Claire Bailey Gynaecology Limited is a private company limited by shares incorporated in England and Wales. The registered office is Springside Cottage, Horn Lane, Evenlode, Gloucestershire, United Kingdom, GL56 0NX.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Turnover
Turnover represents the total invoice value of fees rendered during the period and derives from the provision of services falling within the company's ordinary activities.
1.3
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Office equipment
4 year straight line
Computers
3 year straight line
Motor vehicles
25% reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.4
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
CLAIRE BAILEY GYNAECOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 3 -
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.5
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
1
1
3
Tangible fixed assets
Office equipment
Computers
Motor vehicles
Total
£
£
£
£
Cost
At 1 August 2024
5,386
2,620
46,480
54,486
Additions
469
1,049
1,518
At 31 July 2025
5,855
3,669
46,480
56,004
Depreciation
At 1 August 2024
1,531
1,897
14,463
17,891
Depreciation charged in the year
1,215
511
8,067
9,793
At 31 July 2025
2,746
2,408
22,530
27,684
Carrying amount
At 31 July 2025
3,109
1,261
23,950
28,320
At 31 July 2024
3,855
723
32,017
36,595
CLAIRE BAILEY GYNAECOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 4 -
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
7,519
4,290
Prepayments and other debtors
6,568
6,555
14,087
10,845
5
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
13,900
11,253
Other taxation and social security
61
155
Other creditors
2,961
2,176
16,922
13,584